newsfilter
← Latest News
Business Wire·

Vistagen to Present at The Menopause Society 2025 Annual Meeting

Posters Highlight New Insights into PH80's Effects on Brain and Autonomic Activity Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to